GABAergic Contributions to the Pathophysiology of Depression and the Mechanism of Antidepressant Action

E-ISSN： 1996-3181|6|2|127-140

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.6, Iss.2, 2007-04, pp. : 127-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of dopamine in the mechanism of action of antidepressant drugs

By D'Aquila P.S. Collu M. Gessa G.L. Serra G.

European Journal of Pharmacology, Vol. 405, Iss. 1, 2000-09 ,pp. : 365-373

Elsevier

Access to resources Recommend Favorite

Neurochemistry of the Nucleus Accumbens and its Relevance to Depression and Antidepressant Action in Rodents

Current Neuropharmacology, Vol. 4, Iss. 4, 2006-10 ,pp. : 277-291

Bentham Science Publishers

Access to resources Recommend Favorite

Antidepressant-like action of AGN 2979, a tryptophan hydroxylase activation inhibitor, in a chronic mild stress model of depression in rats

By Gittos M.W. Papp M.

European Neuropsychopharmacology, Vol. 11, Iss. 5, 2001-10 ,pp. : 351-357

Elsevier

Access to resources Recommend Favorite

The serotonin-dopamine interaction is critical for fast-onset action of antidepressant treatment: in vivo studies in an animal model of depression

By Dremencov E. Gispan-Herman I. Rosenstein M. Mendelman A. Overstreet D.H. Zohar J. Yadid G.

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 28, Iss. 1, 2004-01 ,pp. : 141-147

Elsevier

Access to resources Recommend Favorite

Epigenetics, Depression and Antidepressant Treatment

Current Pharmaceutical Design, Vol. 18, Iss. 36, 2012-12 ,pp. : 5879-5889

Bentham Science Publishers

Access to resources Recommend Favorite